Cytostatic sensitivity and MDR in bladder carcinoma cells: Implications for tumor therapy

International Journal of Clinical Pharmacology and Therapeutics

Volumn 38, Issue 4, 2000, Pages 204-208

  Schuldes, H ^a,b   Dolderer, J H ^a   Schoch, C ^a   Bickeboller R ^a   Woodcock, B G ^a  

^a GOETHE UNIVERSITY   (Germany)

^b St Katharinen Hospital   (Germany)

Author keywords

Bile salts; Bladder carcinoma; Cell lines; Linolenic acid; MDR; Membrane structure; R verapamil

Indexed keywords

CISPLATIN; GLYCOPROTEIN P; LINOLENIC ACID; METHOTREXATE; TAUROCHENODEOXYCHOLIC ACID; VERAPAMIL;

ARTICLE; BLADDER CARCINOMA; CELL GROWTH; CELL MEMBRANE FLUIDITY; CYTOSTASIS; CYTOTOXICITY; HUMAN; HUMAN CELL; MEMBRANE STRUCTURE; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION;

EID: 0034034037     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP38204     Document Type: Article

References (18)

1. Bates SE, Regis JI, Robey RW, Zhan Z et al 1994 Chemoresistance in the clinic: overview. Bull Cancer Parish 81: 55-66
2. Bedford P, Shellard SA, Walker MC, Whelan RDH et al 1987 Differentialexpression of collateral sensitivity or resistance to cisplatin in human bladdercarcinoma cell lines pre-exposed in vitro to either x-irradiation or cisplatin. Int J Cancer 40: 681-686
3. Benson MC, Giella J, I.S. Whang, Buttyan R et al 1991 Flow cytometric determinatio of the multidrug resistant phenotype in transitional cell cancer of the bladder: implications and applications. J Urol 146: 982-987
4. Herr HW, Laudone VP, Whitmore JWF 1987 An overview of intrvesical therapyfor superficial bladder tumors. J Urol 138: 1362
5. Hill BT, Hosking LK, Shellard SA, Whelan RD 1989 Comparative effectivness ofmitoxantrone and doxorubicin in overcoming experimentally induced drug-resistance in murine and human tumour cell lines in vitro. Cancer Chemother Pharmacol 23: 2140-2144
6. Jost PC, Griffith OH 1976 Instrumental aspects of spin labeling. In: Berliner LJ (ed) Spin labeling theory and applications, Academic Press, New York, 251-271
7. Keith AD, Sharnoff M, Cohn GE 1973 A summary and evaluation of spin labels used as probes for biological membrane structure. Biochim Biophys Acta 300: 379-419
8. Kimiya K, Naito S, Soejuma T, Sakatmoto N et al 1992 Establishment andcharacterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM. J Urol 148: 441-445
9. Long PJ Jj, Prout GR Jj, Wang YK, Lin C-W 1990 The effect of verapamil on amulti-drug resistant bladder carcinoma cell line and its potential as anintravesical chemotherapeutic agent. J Urol 143: 1053-1056
10. Masters JRW, Hephurgn PJ, Walker L, Highman WJ et al. 1986 Tissue culturemodel of transitional cell carcinoma; characterization of twenty-two human urothelial cell lines. Cancer Research 46: 3630-3636
11. Park J, Shinohara N, Liebert M, Noto L et al 1994 P-glycoprotein expression inbladder cancer. J Urol 151: 43-48
12. Schuldes H, Dolderer J, Knobloch J, Bade S, Bickeböller R, Woodcock BG, Jonas D, Zimmer G 1998 Relationship between plasma membrane fluidity and R-verapamil action in CHO cells. Int J Clin Pharmacol Ther 36(2): 71-73
13. Seemann O, Muscheck M, Siegsmund M, Pilch H, et al 1995 Establishment andcharacterization of a multidrug-resistant human bladder carcinoma cell line RT 112/D21. Urol Res 22: 353-360
14. Shinohara N, Liebert M, Wedemeyer G, Chang JHC et al 1993 Evaluation ofmultiple drug resistance in human bladder cancer cell lines. J Urol 150: 505-509
15. Siegsmund MJ, Marx C, Seemann O, Schummer B, Steidler A, Toktomambetova L, Kohrmann KU, Rassweiler J, Alken P 1999 Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins. Urol Res 27(3): 157-163
16. Sternberg CN, Yagoda A, Scher HI, Watson RC et al 1988 M-VAC (methotrexate,vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol 139: 461-469
17. Sternberg CN 1991 Chemotherapie bei der Behandlung von fortgeschrittenenurothelialen Tumoren. Urologe A 30: 33-44
18. Van Blitterswijk WJ, van Hoeven RP, van de Meer 1981 Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescencepolarization measurements. Biochim Biophys Acta 644: 323-332